Patient Guide: Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 12 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT07085767
Status: 🟢 Enrolling Now
Condition: Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma
Phase: PHASE3

Find a Study Location Near You

This study is available at 12 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Ames, Iowa
  • Scarborough, Maine
  • Kansas City, Missouri
  • • And 9 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily